HQLNYSEFiscal year ends September 30
abrdn Life Sciences Investors
$17.03+0.25 (+1.49%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
abrdn Life Sciences Investors has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements abrdn Life Sciences Investors filed with the SEC
FORM 8-K
Event dated Sep 6, 2023, from SEC EDGAR
Current report on Form 8-K
Event dated Mar 22, 2013, from SEC EDGAR
Current report on Form 8-K
Event dated Mar 23, 2012, from SEC EDGAR
Current report on Form 8-K
Event dated Jun 30, 2011, from SEC EDGAR
Current report on Form 8-K
Event dated May 2, 2011, from SEC EDGAR
Current report on Form 8-K
Event dated Nov 1, 2010, from SEC EDGAR
Current report on Form 8-K
Event dated Apr 5, 2010, from SEC EDGAR
Current report on Form 8-K
Event dated Sep 30, 2009, from SEC EDGAR
Current report on Form 8-K
Event dated Aug 4, 2009, from SEC EDGAR
Current report on Form 8-K
Event dated Jul 18, 2008, from SEC EDGAR